First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer
Canadian Oncology Today · 2025
DOI: 10.58931/cot.2025.2341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Oncology Today, 2025. Verfasst von Arwa Ahmed Abdelrahim und 1 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Biliary tract cancer (BTC) comprises a group of heterogenous malignancies that arise from the bile ducts (intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma) and the gallbladder (gallbladder cancer). Collectively, these malignancies carry a poor prognosis, which is attributed to the advanced stage at presentation. Historically, advanced BTC had a reputation of being less responsive to chemotherapy, a theory that was changed in the last decade, likely due to improved biliary drainage techniques that consequently improve liver function. Few advances have been made in the treatment of advanced and unresectable BTC in the past couple of years.
Zitieren
APA
Abdelrahim, A. A., & Goodwin, R. (2025). First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer. Canadian Oncology Today. https://doi.org/10.58931/cot.2025.2341
Vancouver
Abdelrahim AA, Goodwin R. First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer. Canadian Oncology Today. 2025. doi:10.58931/cot.2025.2341
BibTeX
@article{Abdelrahim2025,
author = {Abdelrahim, Arwa Ahmed and Goodwin, Rachel},
title = {First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer},
journal = {Canadian Oncology Today},
year = {2025},
doi = {10.58931/cot.2025.2341}
}
EUVIMED